Enrichment of tumor cells for cell kinetic analysis in human tumor biopsies using cytokeratin gating

Radiotherapy and Oncology

Volumn 41, Issue 3, 1996, Pages 237-248

  Haustermans, K ^a   Hofland, I ^b   Ramaekers, M ^a   Ivanyi, D ^b   Balm, A J M ^b   Geboes, K ^a   Lerut, T ^a   Van Der Schueren, E ^a   Begg, A C ^b  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

Cell kinetics; Cytokeratin; Flow cytometry

Indexed keywords

ANTIBODY; CYTOKERATIN;

ARTICLE; CELL KINETICS; CLINICAL ARTICLE; CONTROLLED STUDY; ESOPHAGUS CANCER; HEAD AND NECK CANCER; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; TUMOR BIOPSY;

ANEUPLOIDY; ANTIBODIES, MONOCLONAL; BIOPSY; CARCINOMA, SQUAMOUS CELL; CELL CYCLE; DNA, NEOPLASM; ESOPHAGEAL NEOPLASMS; FEASIBILITY STUDIES; FLOW CYTOMETRY; HEAD AND NECK NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; KERATINS;

EID: 0030447594     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-8140(96)01846-4     Document Type: Article

References (36)

1. [1] Awwad, H.K., Khafagy, Y., Barsoum, M., Ezzat, M., El-Attar, I. and Farag, H. Accelerated versus conventional fractionation in the postoperative irradiation of locally advanced head and neck cancer: influence of tumor proliferation. Radiother. Oncol. 25: 261-266, 1992.
2. [2] Banks-Schiegel, S.P. and Harris, C.C. Aberrant expression of keratin proteins and cross-linked envelopes in human esophageal carcinomas. Cancer Res. 44: 1153-1157, 1984.
3. [3] Begg, A.C., McNally, N.J., Schrieve, D.C. and Kärcher, H. A method to measure the duration of DNA synthesis and the potential doubling time from a single sample. Cytometry 6: 620-626, 1985.
4. [4] Begg, A.C., Hofland, I., Bartelink, H., Schraub, S., Bentemps, P. and Le Fur, R. The predictive value of cell kinetic measurements in a European trial of accelerated fractionation in advanced head and neck tumors: an interim report. Int. J. Radiat. Oncol. Biol. Phys. 19: 1449-1453, 1990.
5. [5] Begg, A.C. and Hofland, I. Cell kinetic analysis of mixed populations using three-color fluorescence flow cytometry. Cytometry 12: 445-454, 1991.
6. [6] Begg, A.C., Hofland. I., Van Glabbeke, M., Bartelink, H. and Horiot, J.C., Predictive value of potential doubling time for radiotherapy of head and neck tumor patients: results from the EORTC cooperative trial 22851. Semin. Radiat. Oncol. 1: 22-25, 1992.
7. [7] Bennett, M.H., Wilson, G.D. and Dische, S. Tumor proliferation assessed by combined histological and flowcytometric analysis: implications for therapy in squamous cell carcinoma in the head and neck. Br. J. Cancer 65: 870-878, 1992.
8. [8] Bijman, J.T., Wagener, D.J., van Rennes, H., Wessels, J.M.C. and vandenBroek, P. Flow cytometric evaluation of cell dispersion from human head and neck tumors. Cytometry 6: 334-341, 1985.
9. [9] Bourhis, J., Wilson, G., Wibault, P., Bosq, J., Chavaudra, N. and Janot, F. In vivo measurement of the potential doubling time by flowcytometry in oropharyngeal cancer treated by convential radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 26: 793-799, 1993.
10. [10] Cooke, L.D., Cooke, T.G., Forster, G. and Stell, P.M. Prospective evaluation of cell kinetics in head and neck squamous carcinoma: the relationship to tumor factors and survival. Br. J. Cancer 69: 717-720, 1994.
11. [11] Corvo, R., Giaretti, W., Sanguineti, G., Geido, E., Orecchia, R., Guenzi, M., Margarino, G., Bacigalupa, A., Garaventa, G., Barbieri, M. and Vitale, V. In vivo cell kinetics in head and neck squamous cell carcinomas predicts local control and helps guide radiotherapy regimen. J. Clin. Oncol. 13: 1843-1850, 1995.
12. [12] Dolbaere, F., Gratzner, H.G., Pallavicini, M.G. and Gray, J. Flow cytometric measurement of total DNA content and incorporated bromodeoxyuridine. Proc. Natl. Acad. Sci. USA 80: 5573-5777, 1983.
13. [13] Ensley, J.F., Maciorowski, Z., Pietraszkiewicz, H., Hassan, M., Kish, J., Al-Sarraf, M., Jacobs, J., Weaver, A., Atkinson, D. and Crissman, J. Solid tumor preparation for clinical application of flow cytometry. Cytometry 8: 488-493, 1987.
14. [14] Ensley, J.F., Maciorowski, Z., Hassan, M., Pietraszkiewicz, H., Sakr, W. and Heilbrun, L. K. Variations in DNA aneuploid cell content during tumor dissociation in human colon and head and neck cancers analyzed by flow cytometry. Cytometry 14: 550-558, 1993.
15. [15] Fowler, J.F. How worthwhile are short schedules in radiotherapy?: A series of exploratory calculations. Radiother. Oncol. 18: 165-181, 1990.
16. [16] Fowler, J.F. The phantom of tumor treatment - continually rapid proliferation unmasked. Radiother. Oncol. 22: 156-158, 1991.
17. [17] Grace, M.P., Kim, K.H., True, L.D. and Fuchs, E. Keratin expression in normal esophageal epithelium and squamous cell carcinoma of the esophagus. Cancer Res. 45: 841-846, 1985.
18. [18] Gratzner, H.G. Monoclonal antibody to 5-bromo-and 5-iododeoxyuridine: a new reagent for detection of DNA replication. Science 218: 474-475, 1982.
19. [19] Haustermans, K., Geboes, K., Lerut, T. and van der Schueren, E. Cytokeratin expression in the normal adult human esophageal epithelium: an immunohistochemical study. Diseases of the Esophagus 8: 262-269, 1995.
20. [20] Hendry, J.H., West, C.M.L., Moore, J.V. and Potten, C.S. Tumor stem cells: the relevance of predictive assays for tumor control after radiotherapy. Radiother. Oncol. 30: 11-16, 1994.
21. [21] Ivanyi, D., Minke, J.M.H.M., Hageman, C., Groenveld, E. and van Doornewaard, G. Patterns of expression of feline cytokeratins in healthy epithelia and mammary carcinoma cells. Am. J. Vet. Res. 53: 304-314, 1992.
22. [22] Lochrin, C.A., Wilson, G.D., McNally, N.J., Dische, S. and Saunders, M.I. Tumor cell kinetics, local tumor control, and accelerated radiotherapy: a preliminary report. Int. J. Radiat. Oncol. Biol. Phys. 24: 87-91, 1992.
23. [23] Moll, R., Franke, W.W., Schiller, D.L., Geiger, B. and Krepler, R. The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells. Cell 31: 11-24, 1982.
24. [24] Oud, P.S., Hendrik, J.B.J., Beck, H.L.M., Veldhuizen, J.A.M., Vooijs, G.P., Herman, C.J. and Ramaekers, F.C.S. Flow cytometric analysis and sorting of human endometrial cells after immunocytochemical labeling for cytokeratin using a monoclonal antibody. Cytometry 6: 159-164, 1985.
25. [25] Ramaekers, F.C.S., Beck, H., Vooijs, P. and Herman, C.J. Flowcytometric analysis of mixed cell populations using intermediate filament antibodies. Exp. Cell Res. 153: 249-253, 1984.
26. [26] Ritter, M.A., Albrechtson, J.L., Kim, Y.J. and Kinsella, T.J. Tumor cell kinetics in mixed populations. Cytometry 16: 118-128, 1994.
27. [27] Schaafsma, H.E., Van der Velden, L.A., Manni, J.J., Peters, H., Link, M. and Ruiter, D.J. Increased expression of cytokeratin 8, 18 and vimentin in the invasion front of mucosal squamous cell carcinoma. J. Pathol. 170: 77-86, 1993.
28. [28] Schutte, B., Tinnemans, M.M., Pijpers, G.F., Lenders, M.J. and Ramaekers, F.C.S. Three parameter flow cytometric analysis for simultaneous detection of cytokeratin, proliferation associated antigens and DNA content. Cytometry 21: 177-186, 1995.
29. [29] Shankey, T.V., Rabinovitch, P.S., Bagwell, B., Bauer, K.D., Duque, R.E., Hedley, D.W., Mayall, B.H., Wheeless, L. and Cox, C. Guidelines for implementation of clinical DNA cytometry. International Society for Analytical Cytology. Cytometry 14: 472-427, 1993.
30. [30] Steel, G.G. Growth Kinetics of Tumors. Oxford University Press, Oxford, 1977.
31. [31] Van der Velden, L.A., Schaafsma, H.E., Manni, J.J.M., Ramaekers, F.C.S. and Kuijpers, W. Cytokeratin expression in normal and (pre)malignant head and neck epithelia: an overview. Head and Neck 15: 133-146, 1993.
32. [32] Van Dongen, G.A.M.S., Braakhuis, B.J.M., Hendriks, H.R., Kipp, B.B.A., Bagnay, M. and Snow, G.B. Anti-tumor and differentiation-inducing activity of N,N-Dimethylformamide (DMF) in head and neck cancer xenografts. Int. J. Cancer 43: 285-292, 1989.
33. [33] Wilson, G.D. Assessment of human tumor proliferation using bromodeoxyuridine-current status. Acta Oncol. 30-8: 903-910, 1991.
34. [34] Wingren, S., Stal, O. and Nordenskdold, B. Flow cytometric analysis of S-phase fraction in breast carcinomas using gating on cells containing cytokeratin. Br. J. Cancer 69: 546-549, 1994.
35. [35] Withers, H.R., Taylor, J.M.G. and Maciejewski, B. The hazard of accelerated tumor clonogen repopulation during radiotherapy. Acta Oncol. 27: 131-146, 1988.
36. [36] Yang, K. and Lipkin, M. AE1 cytokeratin reaction patterns in different differentiation states of squamous cell carcinoma of the esophagus. Am. J. Clin. Pathol. 94: 261-269, 1990.